FDA Approves Moderna’s RSV Vaccine

The U.S. Food and Drug Administration has approved Moderna’s respiratory syncytial virus (RSV) vaccine, the company announced on Friday, giving it a shot at much-needed new revenue from a second product. Moderna’s vaccine was approved by the FDA for the prevention of…[#item_full_content]